Clinical Trial Update: Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability [Phase 2]

View source ↗

Summary

This Phase 2 extension study in premanifest Huntington's disease evaluated the safety and tolerability of creatine and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Creatine (creatine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Huntington's Disease | Phase 2 | Status: COMPLETED